A Battle Over Orphan Drug Pricing In The UK
Make a commentBy Ed Silverman // November 22nd, 2010 // 11:46 am
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Oct | Dec » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | ||||
• Pharma Blog » 2010
Pharmalot November, 2010 Archive
Merck, Vytorin & Questionable Oxford Researchers
24 CommentsBy Ed Silverman // November 22nd, 2010 // 9:23 am
Shionogi Needs Sales Reps, But No Reps Need Apply
12 CommentsBy Ed Silverman // November 22nd, 2010 // 8:04 am
DEA Commish, A Delayed Nomination & Pain Meds
11 CommentsBy Ed Silverman // November 19th, 2010 // 12:24 pm
FDA Forces Old Pain Meds Off The Market
3 CommentsBy Ed Silverman // November 19th, 2010 // 11:33 am
Should Regulators Release Trial Data On Request?
6 CommentsBy Ed Silverman // November 19th, 2010 // 9:01 am
Former Bristol-Myers Rep Sues For Overtime Pay
6 CommentsBy Ed Silverman // November 19th, 2010 // 8:15 am
J&J Wins New Trial Over Risperdal Marketing
3 CommentsBy Ed Silverman // November 19th, 2010 // 7:56 am